A number of SFARI Investigators, collaborators and Simons Foundation scientists will present their latest research findings at the American Society of Human Genetics (ASHG) 2020 Virtual Meeting, which will be held October 27–30.
A new collaboration between SFARI and the Nancy Lurie Marks Family Foundation will generate hundreds of induced pluripotent stem cells from individuals with autism and related neurodevelopmental conditions. These cell lines will become available to researchers starting next year.
Louis Reichardt, who has served as director of SFARI since 2013, finished his tenure here on September 28. John Spiro has been appointed interim director of SFARI until a new director is appointed.
SFARI would like to remind investigators to please acknowledge SFARI funding and/or the use of SFARI resources, biospecimens and data in all relevant preprints and publications.
SFARI is pleased to announce that eight genetic rat models of autism spectrum disorder are now available from the Medical College of Wisconsin. These models are being maintained in the outbred Long-Evans background strain and are being behaviorally phenotyped through a partnership with the Simons Initiative for the Developing Brain.
SFARI is pleased to announce that it has selected three fellows in response to the 2020 Bridge to Independence Award request for applications.
New data were recently added to SFARI Gene. This data release included the addition of new genes associated with autism risk, new curated references of copy number variations associated with autism and new mouse models of autism.
SFARI is developing several new initiatives to promote inclusion of underrepresented minorities in autism research and the larger scientific community.